Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
Poland
In shortCentrum Medyczne Enel - Med Spółka Akcyjna is profitable.
Financial health
Mixed
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 0.5% | 18/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 1.3% | 25/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 5.3% | 26/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | – | n/a |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 0.58× | 0/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | – | n/a |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 0.30× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 0.02 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 13.1% | 72/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 9.85× | 100/100 |
| Years with positive free cash flow (last 5) | 4 of 4 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 1 of 4 | 25/100 |
|---|---|---|
| Years of revenue decline (last 5) | 0 of 3 | 100/100 |
| Revenue growth volatility | 8.0% | 82/100 |
| Operating margin volatility | 3.4% | 78/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 15.7% | 100/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2023 · change vs prior year
European data comes from annual reports in ESEF format (since 2020). Industry and ticker are not provided by this source.
Annual figures as reported. Hover a bar or point for the exact value.
The last 4 fiscal years from the company's annual reports.
PLN millions; negative values in parentheses.
| Fiscal year | FY20 | FY21 | FY22 | FY23 |
|---|---|---|---|---|
| Revenue | 400 | 441 | 495 | 619 |
| Cost of revenue | 370 | 419 | 484 | 593 |
| Gross profit | 30 | 22 | 11 | 26 |
| Operating income | 16 | 4.7 | (21) | 3 |
| Interest expense | 21 | 4.9 | 8.7 | 9.9 |
| Pre-tax income | (4.5) | 0.6 | (28) | 9.8 |
| Income tax | (1.1) | 1.5 | (4.4) | 1.6 |
| Net income | (3.4) | (0.9) | (24) | 8.2 |
| Diluted EPS | −zł0.14 | −zł0.04 | −zł0.83 | zł0.29 |
0.02 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
8/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: filings.xbrl.org (ESEF). Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2023 · Data updated Dec 31, 2023